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S U M M A R Y
Objectives: Sepsis is a leading cause of death in critically ill patients, and apoptosis plays a major role in
the pathophysiology of sepsis. Elevated levels of circulating nucleosomes released by apoptotic cells
have been detected in patients with severe sepsis and septic shock. The aim of this study was to evaluate
the diagnostic/prognostic value of circulating nucleosomes in sepsis.
Methods: Seventy-four newly admitted patients with an estimated length of stay in the intensive care
unit of more than 48 h, were prospectively enrolled as cohort 1. The second independent cohort (cohort
2) consisted of 91 post-surgery patients. Patients receiving chemotherapy, those with AIDS, those on
steroid treatment, and those undergoing transplants were excluded. Levels of circulating nucleosomes
within 24 h of admission in both cohorts, and for cohort 1 also on days 3, 5, and 7 and a last time-point of
ICU discharge or at imminent death, were measured and analyzed for their capacity to predict sepsis. The
severity of the inﬂammatory response and organ dysfunction were assessed by cytokine levels and sepsis
scores.
Results: Nucleosome levels on admission in septic patients were signiﬁcantly higher than those
in non-septic controls in both of the cohorts. The area under the receiver operating characteristic
curve for admission nucleosome levels to differentiate septic patients from non-septic patients
was 0.70 (95% conﬁdence interval (CI) 0.51–0.88) in cohort 1, 0.66 (95% CI 0.55–0.79) in cohort 2, and
0.67 (95% CI 0.55–0.79) in all of the subjects. After multiple logistic regression analysis, circulating
nucleosomes remained as an independent predictor of sepsis. Furthermore, the levels of circulating
nucleosomes on admission were signiﬁcantly correlated with the inﬂammatory response and organ
dysfunction in sepsis. Meanwhile, a trend was observed for admission levels of circulating nucleosomes
in non-survivors to be higher than those in survivors.
Conclusions: The level of circulating nucleosomes in the serum has a predictive value for sepsis and
organ dysfunction and may serve as a candidate biomarker for the diagnosis/prognosis of sepsis. Further
studies are warranted to conﬁrm the present ﬁndings.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Sepsis is a leading cause of morbidity and mortality in critical
illness throughout the world.1 The pathophysiology of sepsis is
complex and remains to be delineated; the host immune response
and apoptosis, as well as the coagulation/ﬁbrinolysis system, are
involved as key mechanisms.1,2 Despite recent advances in
supportive care and potential therapeutic strategies, the overall
mortality rate of patients with septic shock remains high, ranging* Corresponding author. Tel.: +86 1385 7161019; fax: +86 571 86091799.
E-mail address: xiangming_fang@163.com (X. Fang).
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http://dx.doi.org/10.1016/j.ijid.2012.03.007from 30% to 70%.3–5 Early screening and diagnosis of sepsis are
particularly important for those patients at high risk of sepsis.6
Currently, useful biomarkers for predicting sepsis are limited to
certain molecules, such as procalcitonin (PCT), C-reactive protein
(CRP), and soluble triggering receptor expressed on myeloid cells
(sTREM-1).7 Investigators are still searching for new efﬁcacious
candidates for the prediction of sepsis.
Nucleosomes are complexes formed by DNA and histone
proteins. The core particles of nucleosomes comprise an octamer
of the double-represented histones H2A–H2B and H3–H4, sur-
rounded by 146 base pairs of double-stranded DNA. Nucleosomes
are mainly released by apoptotic cell death.8,9 Under physiological
conditions, the nucleosomes are packed into membrane-boundses. Published by Elsevier Ltd. All rights reserved.
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case of a high rate of apoptosis, these phagocytosing mechanisms are
saturated or impaired, leading to higher concentrations of nucleo-
somes in the circulation.9,10 Elevated levels of circulating nucleo-
somes have been detected in various non-malignant and malignant
diseases, such as severe sepsis and septic shock, cerebral stroke,
systemic lupus erythematosus, and cancer.9,11–13 Of note, circulat-
ing nucleosomes have been demonstrated as a new diagnostic tool
for the early estimation of the response to cytotoxic cancer therapy
and as a new prognostic marker in early cerebral stroke.8,12
However, the diagnostic/prognostic value of circulating nucleo-
somes in sepsis remains unknown.
In this study, we prospectively investigated circulating
nucleosomes in critically ill patients, and assessed the potential
role of circulating nucleosomes in predicting the incidence and
outcome of sepsis.
2. Materials and methods
2.1. Study population
All patients who were newly hospitalized at two teaching
hospitals in Zhejiang Province between June and November 2009,
who had an estimated length of stay in the surgical intensive care
unit (ICU) of more than 48 h, were prospectively enrolled in the
study as cohort 1. The diagnosis of sepsis, severe sepsis, and septic
shock met the criteria recommended by the American College of
Chest Physicians and the Society of Critical Care Medicine
Consensus Conference.14 Exclusion criteria were age younger than
18 years, advanced malignancy or other conditions resulting in a
shortened life expectancy (4 weeks), and pregnancy. Patients
were also excluded if they were immunocompromised because of
treatment with corticosteroids or chemotherapy, receipt of bone
marrow or organ transplants, or AIDS.
The subjects in cohort 2 were post-surgery patients who were
prospectively included in the study from the surgical ICUs of two
hospitals of Zhejiang University from August to November 2011.
The inclusion and exclusion criteria were the same as those for
cohort 1.
The study was approved by the local institutional review boards
and was performed in accordance with the ethical standards laid
down in the 1964 Declaration of Helsinki. Informed consent was
obtained from all patients or their relatives.
2.2. Data collection
On admission to the surgical ICU, the following items were
recorded for each patient: age, sex, reason for admission to the ICU,
and principal diagnosis. The acute physiology and chronic health
evaluation II (APACHE II) score was obtained within 24 h of
admission. The sequential organ failure assessment (SOFA) score
was calculated daily. The maximum SOFA score (SOFAmax) was
deﬁned as the highest score for the related system reached during
the ICU stay and was used to express the worst organ dysfunction
status attained during the ICU stay. Results of routine blood tests and
microbiological culture were also recorded. Survival or death in the
ICU was evaluated during a follow-up period of 28 days. All of the
medical records of each patient were reviewed by two senior
intensivists who were blinded to the circulating levels of nucleo-
somes. Agreement on the diagnosis was achieved in all cases.
2.3. Measurement of circulating nucleosomes, CRP, sTREM-1, PCT, and
cytokines
Coagulated and ethylenediaminetetraacetic acid (EDTA) anti-
coagulated venous blood samples were drawn within 24 h ofadmission in both of the cohorts, and for cohort 1 also on days 3, 5,
and 7 and a last time-point of ICU discharge or at imminent death
in the non-survivors. The serum samples for nucleosome
determination were centrifuged at 3000 g for 15 min and treated
with 10 mmol/l EDTA (pH 8) immediately after centrifugation.
Plasma was isolated by centrifugation at 3000 rpm for 3 min. Both
of the serum and plasma samples were aliquoted and stored at
80 8C until further analysis.
The preanalytic handling of the serum samples for nucleosome
measurement was performed as previously described.15 Circulat-
ing nucleosome and sTREM-1 levels at each time-point in cohort 1
and the admission levels of these two parameters in cohort 2, and
interleukin-6 (IL-6) and interleukin-10 (IL-10) concentrations at
each time-point in cohort 1, were assayed using commercially
available ELISA kits (nucleosomes: Cell Death Detection ELISAPLUS,
Roche, Mannheim, Germany; sTREM-1, IL-6, and IL-10: R&D
Systems, Minneapolis, MN, USA). Plasma PCT concentrations on
the day of admission in both of the cohorts were measured using an
immunoassay technique and a chemiluminescent detection
system, in accordance with the manufacturer’s protocol (Brahms
Diagnostica, Berlin, Germany). Serum levels of CRP on the day of
admission in both of the cohorts were detected with the
ultrasensitive latex immunoassay CRP Vario (Abbott Diagnostics).
White blood cell (WBC) counts in whole blood were quantiﬁed
routinely by standardized clinical biochemical methods.
Nucleosomes were quantiﬁed in arbitrary units (AU) in
accordance with the manufacture’s instructions. The maximum
concentrations of IL-10 and IL-6 were deﬁned as the highest values
in the collected samples for each patient in cohort 1.
2.4. Statistical analysis
Data are presented as the median with the range unless stated
otherwise. Differences in continuous variables were evaluated
with the Mann–Whitney test or the Kruskal–Wallis test with
Dunn’s multiple comparison test. Differences in categorical data
were compared using the Chi-square test and Fisher’s exact test.
Receiver operating characteristic (ROC) curves were constructed to
explore the relationship between the sensitivity and speciﬁcity of
circulating nucleosomes and sTREM-1, as well as PCT, CRP, and
WBC counts, in discriminating patients with sepsis from those
without sepsis. A multiple stepwise logistic-regression model was
used to evaluate the diagnostic value of circulating nucleosomes
for sepsis, which included admission levels of sTREM-1, PCT, and
CRP, as well as WBC counts, as covariates. The relationships
between circulating nucleosomes and clinical or biological features
were assessed with Spearman’s correlation test. The statistical
analyses were performed using SPSS 16.0 for Windows (SPSS Inc.,
Chicago, IL, USA) and GraphPad Prism 5.00 for Windows (GraphPad
Software Inc., La Jolla, CA, USA). A two-tailed p-value of less than
0.05 was considered statistically signiﬁcant.
3. Results
3.1. Characteristics of the study population
During the study period, a total of 477 patients were admitted to
the two ICUs. Three hundred and ﬁfty-three patients stayed in the ICU
for less than 48 h, 12 patients were younger than 18 years of age, 26
patients were admitted with advanced malignancy or other condi-
tions resulting in a shortened life expectancy (4 weeks), and three
patients were pregnant; a further nine patients were immunocom-
promised because of treatment with corticosteroids or chemotherapy.
Finally, 74 patients were included in the present study as cohort 1.
The basic characteristics of the study subjects are shown in
Table 1. Twenty-nine of the cohort 1 patients (39.2%) did not suffer
Table 1
Patient characteristics










Age (years) 54 (24–87) 44.5 (20–75) 0.009 59 (20–89) 57 (24–88) 0.75
Sex, n (%) 0.81 1.00
Male 28 (62.2) 17 (58.6) 56 (80) 17 (81.0)
Female 17 (37.8) 12 (41.4) 14 (20) 4 (19.0)
APACHE II on admission 19 (7–37) 19 (1–31) 0.79 19 (6–34) 15 (2–30) 0.053
SOFAmax score 7.5 (2–18) 5 (1–18) 0.15 7 (1–23) 3.5 (0–19) 0.0017
Length of ICU stay (days) 8 (2–35) 3 (2–6) 0.0002 12.5 (2–43) 5 (2–11) 0.0019
28-day mortality rate, n (%) 13 (28.9) 2 (6.9) 0.036 21 (30) 4 (19.0) 0.41
Data are expressed as the median (range), or number (%) where indicated. APACHE II, acute physiology and chronic health evaluation II score; SOFAmax, maximum sequential
organ failure assessment score; ICU, intensive care unit.
Figure 1. Time course of (A) circulating nucleosome levels and (B) plasma levels of
sTREM-1, in septic patients and controls. Data are expressed as the median
(interquartile range).
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trauma and major surgery. In the sepsis group, multiple trauma
(51.1%) was the most frequent initial diagnosis for the septic
patients, followed by peritonitis (20%) and severe acute pancreati-
tis (11.1%). Microbiological evidence showed that 37 of 45 septic
patients experienced a documented infection, of whom 22 had a
Gram-negative infection, eight had a Gram-positive infection, and
seven had a fungal infection. The remaining eight patients had
clinically suspected infections as stated by the senior intensivist.
The major sources of infection were the respiratory tract (40%) and
the bloodstream (33.3%). In addition, out of the 45 patients, 18
(40%) developed sepsis, 16 (35.6%) severe sepsis, and 11 (24.4%)
developed septic shock.
Cohort 2 consisted of 91 post-surgery patients; 70 were
diagnosed with sepsis and 21 patients served as controls (Table
1). In cohort 2 patients, multiple trauma (25.3%) was the most
frequent reason for the surgery, followed by severe acute
pancreatitis (20.9%), intestinal obstruction (20.9%), and other
reasons (32.9%). In the sepsis group, 37 (52.8%) had a Gram-
negative infection, 11 (15.7%) had a Gram-positive infection, and
13 (18.6%) had a fungal infection. The other nine patients had
clinically suspected infections as stated by the senior intensivist.
The major sources of infection were the invasive vessel (22.8%), the
bloodstream (21.4%), the respiratory tract (17.1%), and the
abdomen (14.3%). In addition, 34 patients (48.6%) developed
severe sepsis and 14 (20%) developed septic shock.
3.2. Circulating nucleosome levels and the incidence of sepsis
Changes in the serum levels of circulating nucleosomes and
plasma levels of sTREM-1 in the septic patients and controls in
cohort 1 on days 1, 3, 5, 7, and the last time point (discharge from
the ICU or imminent death) are shown in Figure 1. In septic
patients, the serum levels of circulating nucleosomes showed a
trend to decline during the ICU stay, while plasma levels of sTREM-
1 remained high. Since only six control patients were still in the ICU
on day 3 and only one control patient was still in the ICU on day 6,
the results for the change in serum levels of circulating
nucleosomes and plasma levels of sTREM-1 may be compromised
in this control group.
For evaluating the diagnostic value of circulating nucleosomes,
the admission levels of the potential biomarkers were analyzed.
For cohort 1, the levels of circulating nucleosomes, sTREM-1, and
CRP on admission in the septic patients were signiﬁcantly higher
than those in the controls (Table 2). The capacity of these
parameters to differentiate the septic patients from non-septic
patients was assessed with a ROC curve analysis. Areas under the
ROC curves were 0.70 (95% conﬁdence interval (CI) 0.51–0.88) for
nucleosomes, 0.68 (95% CI 0.46–0.89) for sTREM-1, and 0.72 (95%
CI 0.56–0.87) for CRP, as well as 0.64 (95% CI 0.45–0.84) for PCT and0.40 (95% CI 0.20–0.60) for WBC count (Figure 2A). The best cutoff
value of circulating nucleosomes for predicting sepsis was 2.09 AU,
which had a sensitivity of 64% and a speciﬁcity of 76%.
To validate the above ﬁndings, we replicated the same analysis
in a second independent post-surgery cohort (cohort 2). Compared
to the controls, the septic patients showed signiﬁcantly elevated
levels of circulating nucleosomes, sTREM-1, and CRP on the day of
admission (Table 2). Areas under the ROC curves for nucleosomes,
sTREM-1, CRP, PCT, and WBC count were 0.66 (95% CI 0.55–0.79),
0.67 (95% CI 0.52–0.81), 0.69 (95% CI 0.57–0.81), 0.48 (95% CI 0.34–
0.62), and 0.57 (95% CI 0.43–0.71), respectively (Figure 2B). The
best cutoff value of circulating nucleosomes for predicting sepsis
was 0.78 AU, which yielded a sensitivity of 86% and a speciﬁcity
of 52%.
Table 2
Comparison of potential biomarkers on the day of admission for predicting sepsis in the studied cohort
Parameters Cohort 1 Cohort 2
Sepsis (n = 45) Control (n = 29) p-Value Sepsis (n = 70) Control (n = 21) p-Value
Nucleosome (AU) 2.98 (0.30–12.60) 1.29 (0.11–9.86) 0.0028 1.86 (0.40–10.27) 0.78 (0.35–9.69) 0.028
sTREM-1 (pg/ml) 161.30 (60.03–1123.00) 99.42 (37.08–276.30) 0.0003 92.09 (26.31–476.30) 72.60 (16.82–432.80) 0.023
CRP (mg/l) 124.50 (1.89–420.00) 54.46 (12.46–110.80) 0.038 110.20 (7.61–267.00) 54.04 (3.26–161.00) 0.008
PCT (mg/l) 2.24 (0.02–93.60) 1.23 (0.03–4.64) 0.21 0.98 (0.02–100.00) 1.17 (0.04–41.87) 0.80
WBC (109/l) 13.10 (2.40–35.60) 13.10 (6.20–29.00) 0.75 13.00 (1.20–43.40) 9.70 (3.40–37.40) 0.33
Data are expressed as the median (range). AU, arbitrary units; sTREM-1, soluble triggering receptor expressed on myeloid cells 1; CRP, C-reactive protein; PCT, procalcitonin;
WBC, white blood cell count.
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for these variables to differentiate the septic patients from non-
septic patients was 0.67 (95% CI 0.55–0.79) for nucleosomes, 0.67
(95% CI 0.55–0.78) for sTREM-1, 0.70 (95% CI 0.60–0.79) for CRP,
0.54 (95% CI 0.43–0.66) for PCT, and 0.52 (95% CI 0.41–0.64) for
WBC count (Figure 2C). In a multiple logistic regression analysis,
circulating nucleosomes remained an independent predictor of
sepsis (odds ratio 4.60, 95% CI 1.62–12.78; p = 0.004).
In addition, there was no signiﬁcant difference in the
admission levels of circulating nucleosomes between Gram-
negative and Gram-positive sepsis in both of the cohorts (data not
shown).Figure 2. The receiver operating characteristic (ROC) curve for admission levels of circu
septic and non-septic patients in (A) cohort 1, (B) cohort 2, and (C) the entire study po3.3. Circulating nucleosome levels and the inﬂammatory response in
sepsis
The relationship between serum levels of circulating nucleo-
somes and the immune response was investigated in cohort 1. The
changes in levels of cytokines IL-6 and IL-10 over time in septic
patients and controls are shown in Figure 3A and Figure 3B; these
did not correlate with the evolution of circulating nucleosomes or
sTREM-1 (p > 0.05). When the admission levels of circulating
nucleosomes and the severity of the inﬂammatory response were
analyzed, we found that at a cutoff value of 2.09 AU for circulating
nucleosomes, the septic patients with higher levels of nucleosomeslating nucleosomes, sTREM-1, and CRP, as well as PCT and WBC, in differentiating
pulation.
Figure 3. Time course of plasma levels of (A) IL-6 and (B) IL-10 in septic patients and controls from cohort 1, and (C) the maximum IL-6 concentrations and (D) the maximum
IL-10 concentrations in septic patients with nucleosome levels higher than 2.09 and those with nucleosome levels lower than 2.09.
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the maximum of IL-10 and IL-6 levels at the sampled time-points)
than those with lower levels of nucleosomes (median of IL-6
maximum: 194.90 pg/ml vs. 87.64 pg/ml, p = 0.03; median of IL-10
maximum: 137.30 pg/ml vs. 37.91 pg/ml, p = 0.004; Figure 3C and
Figure 3D). However, the admission levels of sTREM-1 were not
associated with the cytokine levels.
3.4. Circulating nucleosome levels and the severity/outcome of sepsis
To evaluate the relationship of circulating nucleosome levels
and the severity/outcome of sepsis, the two cohorts were
combined in the further analysis. The admission level of circulating
nucleosomes was associated with the APACHE II score (nucleo-
some: r = 0.24, p = 0.01; Figure 4A). The organ function in septicFigure 4. The correlation of circulating nucleosome levels on admission with (A) Apatients was evaluated using the SOFA score. The level of
circulating nucleosomes on admission was signiﬁcantly correlated
with SOFAmax during the ICU stay (nucleosome: r = 0.21, p = 0.03;
Figure 4B).
If the septic patients were divided into three subgroups – sepsis,
severe sepsis, and septic shock – the admission levels of circulating
nucleosomes were comparable among these groups. Furthermore,
no statistically signiﬁcant differences were seen in the levels of
circulating nucleosomes when the patients developed sepsis or
severe sepsis or septic shock during their ICU stay (data not shown).
The association between the admission levels of circulating
nucleosomes and mortality in sepsis was also assessed. There was a
trend towards admission levels of circulating nucleosomes in non-
survivors being higher than those in survivors (median 2.58 AU vs.
1.97 AU; p = 0.06).PACHE II score (r = 0.24, p = 0.01) and (B) SOFAmax score (r = 0.21, p = 0.03).
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The current prospective study demonstrated that serum levels
of circulating nucleosomes on admission were signiﬁcantly
elevated in septic patients when compared to those in non-septic
patients. The area under the ROC curve for circulating nucleosomes
to discriminate patients with sepsis from those without sepsis was
0.67 (95% CI 0.55–0.79). Multiple logistic regression analysis
conﬁrmed circulating nucleosomes as an independent predictor of
sepsis. Furthermore, the higher levels of circulating nucleosomes
on admission were signiﬁcantly correlated with a more immuno-
suppressive response and worse organ function in septic patients.
These ﬁndings suggest that circulating nucleosomes may serve as a
valuable candidate biomarker for predicting sepsis and organ
dysfunction.
Sepsis is thought to be the most noteworthy clinical disorder in
which apoptosis occurs.16 A marked increase in apoptosis has been
observed in patients with sepsis compared with critically ill
patients without sepsis and healthy controls.17 Apoptosis presents
a major mechanism of nucleosome liberation. This extraordinary
apoptosis in sepsis releases numerous nucleosomes, which may
overload the nucleosome clearance mechanism, eventually result-
ing in elevated levels of nucleosomes in the circulation. Hence it
was not surprising that septic patients displayed high levels of
nucleosomes, which were correlated with the APACHE II score.
Furthermore, the apoptosis during sepsis, especially the deletion of
T and B cells, not only impairs the adaptive immune response, but
also induces anergy and immunosuppression by releasing anti-
inﬂammatory cytokines such as IL-10.17 Therefore, it was not
surprising that septic patients with higher levels of circulating
nucleosomes experienced more severe immunoparalysis (as
indicted by the maximum of the IL-10 concentrations). In addition,
studies have found that non-immune cells such as gut mucosal
epithelial cells, lung epithelial cells, hepatocytes, and endothelial
cells, exhibit apoptotic changes during clinical and experimental
sepsis.17 This may contribute to the organ dysfunction following
the onset of sepsis and explain the correlation between circulating
levels of nucleosomes and the severity of organ dysfunction, which
was assessed by SOFA score in the current study.
TREM-1 is a member of the immunoglobulin superfamily and is
expressed on myeloid cells. sTREM-1 is a soluble form of this
protein and is shed from the membrane of activated myeloid
cells.18,19 Studies have shown that sTREM-1 is a new emergent
biomarker in infectious and inﬂammatory diseases such as
sepsis.20,7 Due to the persistently activated myeloid cells and
the upregulated expression of TREM-1 on myeloid cells during
sepsis, the concentration of sTREM-1 remains at high levels in
septic patients. Although the role of elevated levels of sTREM-1 in
sepsis remains unclear, a previous study in a mouse model of septic
shock showed that the administration of the soluble form of TREM-
1 was protective against hyper-responsiveness and death.21
sTREM-1 may be linked to the blocking of cell surface TREM-1
binding to its endogenous ligand, which eventually lessens the
inﬂammatory reaction. Therefore, plasma levels of sTREM-1 are
not associated with the severity of the inﬂammatory response in
sepsis.
There are several advantages to the potential clinical applica-
tion of detecting circulating nucleosomes. First, circulating
nucleosomes are assayed in serum. Apoptosis is characterized
by the deformation of the cell membrane, cell shrinkage,
chromatin condensation, nuclear fragmentation, and disruption
of the mitochondrial transmembrane potential.16 Assessment of
these apoptotic changes is mainly performed in cells. However,
apoptosis in sepsis occurs not only in peripheral blood cells, but
also in various organs, the latter making measurement of apoptosis
unpractical in septic patients. Serum samples are easily obtainableand it has been shown that shaking, rolling, and storing of serum
does not impact the levels of circulating nucleosomes.8 Second, the
assay of circulating nucleosomes can be done using commercially
available ELISA kits, with high reproducibility. Although quantiﬁ-
cation of cell-free DNA by real-time PCR is accepted as the standard
for the evaluation of apoptosis, measuring circulating nucleosomes
with an ELISA technique showed a good correlation with the
standard method and has its merits in terms of cost, time, and
labor.22 Third, circulating nucleosomes have the diagnostic
capacity to discriminate sepsis from non-sepsis comparable to
that of sTREM-1, a well-characterized biomarker of sepsis.7,23
Efforts have been made in recent decades to identify suitable early
markers of sepsis, however only a few biomarkers have been
applied in clinical practice. The early elevated circulating levels of
nucleosomes in patients newly admitted to the ICU will be very
helpful to screen those at high risk of sepsis and to guide physicians
in clinical decision-making.
Zeerleder and colleagues reported that compared to patients
with fever and systemic inﬂammatory response syndrome,
patients with severe sepsis and septic shock had stepwise elevated
plasma levels of nucleosomes.11 However in Zeerleder’s study, the
lack of a group of patients only with sepsis made it unclear whether
the increased levels of nucleosomes resulted from sepsis or organ
dysfunction. Furthermore, a correction for multiple comparisons
among the four deﬁned groups was absent in the statistical
analysis, which may explain the discrepant ﬁndings between the
two studies. In addition, Zeerleder et al. used an in-house
developed ELISA method to detect the plasma levels of nucleo-
somes, while a commercial ELISA kit was used to assay the serum
levels of nucleosomes in the current study. The different
techniques and samples applied may also have contributed to
the diverse ﬁndings between the two studies. Of note, a trend
towards higher nucleosome levels in non-surviving septic patients
than in survivors was observed in both studies.
There are limitations in the current study that should be noted.
First, previous studies have shown plasma cell-free DNA to be a
predictor of mortality in severe sepsis and septic shock.24,25
Recently, cell-free DNA/neutrophil extracellular traps, as well as
extracellular histones, were elaborated to play important roles in
the immune defense against bacteria and inﬂammation.26,27
Extracellular histones were found to be major mediators of death
in sepsis.27 Combined measurement of plasma DNA, histones, and
nucleosomes may provide new insight into the diagnosis and
prognosis of sepsis. Limited by the analytical methodology, the
current study did not detect histone molecules in the circulation.
Second, the levels of circulating nucleosomes were not absolutely
quantiﬁed, which may hamper the application of this predictor in
clinical diagnosis. The third limitation is the small study
population, which may compromise the results of the relationship
of the nucleosome levels and the severity/outcome of sepsis. A
much larger study cohort is required to conﬁrm the present
ﬁndings and would also allow the prognostic relevance of changes
in circulating nucleosomes to be assessed. Further studies
addressing the questions raised above will be undertaken.
In summary, the present study demonstrated that plasma levels
of circulating nucleosomes on admission could distinguish septic
patients from non-septic critically ill patients, and that these levels
are correlated with the severity of the immunosuppressive
response and organ dysfunction in sepsis. These ﬁndings suggest
that circulating nucleosomes may serve as a candidate biomarker
for predicting sepsis and organ dysfunction.
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